Japanese pharmaceuticals giant Daiichi Sankyo has raised Rs201.46 billion ($3.2 billion) from the sale of its entire 8.9% stake in Sun Pharmaceuticals, closing the book on its ill-fated foray into India.
¬ Haymarket Media Limited. All rights reserved.
